Investors didn’t seem pleased with a solid earnings and revenue beat from
CVS Health,
with shares in the healthcare company heading lower on Wednesday after the company slashed its full-year guidance for the third consecutive quarter.
CVS
(ticker: CVS) reported earnings of $2.21 a share on revenue of $89.8 billion, firmly topping expectations among analysts surveyed by FactSet of earnings of $2.13 a share on revenue of $88.3 billion.
But CVS lowered its guidance range for diluted earnings per share measured under U.S. Generally Accepted Accounting Principles. The company said it now sees earnings by this metric in a range of $6.37 to $6.61 a share. CVS said in February that earnings could be $7.73 to $7.93 a share in 2023 but has revised this range lower in both May and August.
Shares in CVS fell 1% in premarket trading on Wednesday.
Write to Jack Denton at [email protected]
Read the full article here